Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The international developer, manufacturer, and regulatory services provider for rapid diagnostic tests and medtech announces the launch of a seaweed-based alternative housing for its contract development and manufacturing customers for the development and manufacture of lateral flow tests.</li>
<li>The Company has agreed an exclusive supply agreement with Wolverhampton based Symbio Technologies Ltd for the supply of compostable bio-based material derived from red-seaweed which can be used to produce lateral flow cassettes via standard injection moulding techniques.</li>
<li>This option will provide an alternative to the standard plastic houses that are currently used and create opportunity for Abingdon customers to significantly reduce their plastic waste.</li>
</ul>


The international developer, manufacturer, and regulatory services provider for rapid diagnostic tests and medtech announces the launch of a seaweed-based alternative housing for its contract development and manufacturing customers for the development and manufacture of lateral flow tests.
The Company has agreed an exclusive supply agreement with Wolverhampton based Symbio Technologies Ltd for the supply of compostable bio-based material derived from red-seaweed which can be used to produce lateral flow cassettes via standard injection moulding techniques.
This option will provide an alternative to the standard plastic houses that are currently used and create opportunity for Abingdon customers to significantly reduce their plastic waste.


Aura Energy Ltd - Hybridan Small Cap Feast: 06 November 2025

<ul>
<li>The developer, manufacturer, and distributor of high quality and effective rapid tests reports interim results to December 2024.</li>
<li>Financial highlights include a £5.2m placing, a 28% increase in Revenue to £3.1m, but with an Operating loss of £2.6m up from a loss of £1.2m in H123 as a result of investments in growth initiatives.</li>
<li>The adjusted EBITDA loss was £1.9m and an improved EBITDA performance is expected in H2 due to forecast revenue growth as key strategic milestones are passed, such as the acquisition of CS Lifesciences, the opening of Abingdon Analytical in Doncaster, and the commencement of work in April from the new US site. </li>
</ul>


The developer, manufacturer, and distributor of high quality and effective rapid tests reports interim results to December 2024.
Financial highlights include a £5.2m placing, a 28% increase in Revenue to £3.1m, but with an Operating loss of £2.6m up from a loss of £1.2m in H123 as a result of investments in growth initiatives.
The adjusted EBITDA loss was £1.9m and an improved EBITDA performance is expected in H2 due to forecast revenue growth as key strategic milestones are passed, such as the acquisition of CS Lifesciences, the opening of Abingdon Analytical in Doncaster, and the commencement of work in April from the new US site. 


Duplicate of Hybridan Small Cap Feast: 24/03/2025

Australia

Aura Energy Limited operates as an Australian based minerals company. The Company owns, develops, acquires, and manages uranium and polymetallic projects in Europe and Africa.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aura Energy (AURA LN)

Aura Energy Ltd - Hybridan Small Cap Feast: 06 November 2025

The international developer, manufacturer, and regulatory services provider for rapid diagnostic tests and medtech announces the launch of a...

Hybridan

Duplicate of Hybridan Small Cap Feast: 24/03/2025

The developer, manufacturer, and distributor of high quality and effective rapid tests reports interim results to December 2024.

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)